Qube Research & Technologies (QRT)
TXMD icon

Qube Research & Technologies (QRT)’s TherapeuticsMD TXMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$4 – 4132
2024
Q2 		$4 Hold
2
– – ﹤0.01% 3666
2024
Q1 		$5 Hold
2
– – ﹤0.01% 4331
2023
Q4 		$5 Hold
2
– – ﹤0.01% 4210
2023
Q3 		$6 Buy
+2
New +$8 ﹤0.01% 3964
2022
Q3 		– Sell
-22,055
Closed -$219K – 3038
2022
Q2 		$219K Buy
+22,055
New +$211K ﹤0.01% 1697
2021
Q4 		– Sell
-8,705
Closed -$323K – 2982
2021
Q3 		$323K Buy
8,705
+7,955
+1,061% +$353K ﹤0.01% 1455
2021
Q2 		$45K Buy
750
+310
+70% +$18.8K ﹤0.01% 2031
2021
Q1 		$29K Buy
+440
New +$34.4K ﹤0.01% 1805

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TXMD Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of TherapeuticsMD (TXMD) in Q3 2024, closing a stake of 2 shares — an estimated $4 sold.

Qube Research & Technologies (QRT) first reported a position in TXMD in Q1 2021 and held it in 8 quarters. The position peaked at $323K in Q3 2021. 37 funds tracked by Wall St. Rank hold TXMD as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining TherapeuticsMD position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2 TherapeuticsMD shares in Q3 2024, an estimated $4.
  • Qube Research & Technologies (QRT) first reported a position in TherapeuticsMD in Q1 2021 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s TherapeuticsMD position peaked at $323K in Q3 2021.
  • 37 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.